Sachetta’s Bio-Rad Laboratories Class A BIO Stock Holding History

Sachetta’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.76K	Buy	6 +1	+20%	+$284	﹤0.01%	849
2026 Q1	$1.39K	Hold	5	–	–	﹤0.01%	951
2025 Q4	$1.51K	Hold	5	–	–	﹤0.01%	840
2025 Q3	$1.4K	Hold	5	–	–	﹤0.01%	909
2025 Q2	$1.21K	Buy	+5	New	+$1.18K	﹤0.01%	953
2025 Q1	–	Sell	-7	Closed	-$2.3K	–	1131
2024 Q4	$2.3K	Buy	7 +3	+75%	+$1.02K	﹤0.01%	790
2024 Q3	$1.34K	Hold	4	–	–	﹤0.01%	979
2024 Q2	$1.36K	Buy	4 +2	+100%	+$582	﹤0.01%	957
2024 Q1	$646	Hold	2	–	–	﹤0.01%	1019
2023 Q4	$646	Buy	+2	New	+$627	﹤0.01%	1019

Other funds holding BIO

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

SGH

Sivik Global Healthcare Greenwich, Connecticut $132M AUM 24.1% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $5.7B AUM 35.76% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

PAS

Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return

Sachetta's BIO Position: Q2 2026 in Review

Sachetta increased its Bio-Rad Laboratories Class A (BIO) stake by 20% in Q2 2026, buying an estimated $284 and bringing the position to 6 shares worth $1.76K. The position accounts for ﹤0.01% of the portfolio, ranked #849.

Sachetta first reported a position in BIO in Q4 2023 and has held it in 10 quarters since. The position peaked at $2.3K in Q4 2024. 46 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

Sachetta held 6 shares of Bio-Rad Laboratories Class A worth $1.76K as of Q2 2026.
Sachetta bought 1 Bio-Rad Laboratories Class A share in Q2 2026, an estimated $284.
Bio-Rad Laboratories Class A made up ﹤0.01% of Sachetta's portfolio in Q2 2026, its #849 holding.
Sachetta first reported a position in Bio-Rad Laboratories Class A in Q4 2023 and has held it in 10 quarters since.
Sachetta's Bio-Rad Laboratories Class A position peaked at $2.3K in Q4 2024.
46 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.